These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19782904)

  • 1. Fatal lactic acidosis after prolonged linezolid exposure for treatment of multidrug-resistant tuberculosis.
    Boutoille D; Grossi O; Depatureaux A; Tattevin P
    Eur J Intern Med; 2009 Oct; 20(6):e134-5. PubMed ID: 19782904
    [No Abstract]   [Full Text] [Related]  

  • 2. Early linezolid-associated lactic acidosis in a patient treated for tuberculous spondylodiscitis.
    Scotton P; Fuser R; Torresan S; Carniato A; Giobbia M; Rossi C; Inojosa WO; Vaglia A
    Infection; 2008 Aug; 36(4):387-8. PubMed ID: 18642110
    [No Abstract]   [Full Text] [Related]  

  • 3. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
    Nam HS; Koh WJ; Kwon OJ; Cho SN; Shim TS
    Int J Antimicrob Agents; 2009 Jan; 33(1):92-3. PubMed ID: 18789655
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal lactic acidosis associated with linezolid therapy.
    Djibré M; Pham T; Denis M; Pras Landre V; Fartoukh M
    Infection; 2015 Feb; 43(1):125-6. PubMed ID: 25326668
    [No Abstract]   [Full Text] [Related]  

  • 5. Linezolid-induced lactic acidosis.
    Apodaca AA; Rakita RM
    N Engl J Med; 2003 Jan; 348(1):86-7. PubMed ID: 12510056
    [No Abstract]   [Full Text] [Related]  

  • 6. Linezolid-induced lactic acidosis followed by severe hypophosphatemia after discontinuation of linezolid.
    Miyawaki A; Ueda T; Nakao A; Adachi M; Ohya M; Yamada I; Takesue Y; Kotani J
    Surg Infect (Larchmt); 2013 Apr; 14(2):229-30. PubMed ID: 23464676
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases.
    von der Lippe B; Sandven P; Brubakk O
    J Infect; 2006 Feb; 52(2):92-6. PubMed ID: 15907341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mixed, and not just lactic, acidosis in a patient on linezolid].
    Prieto de Paula JM; Franco Hidalgo S; Mayor Toranzo E; Gutiérrez PP
    Enferm Infecc Microbiol Clin; 2010; 28(7):481-2. PubMed ID: 20417990
    [No Abstract]   [Full Text] [Related]  

  • 9. Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis.
    Yew WW; Chau CH; Wen KH
    Int J Tuberc Lung Dis; 2008 Mar; 12(3):345-6. PubMed ID: 18284844
    [No Abstract]   [Full Text] [Related]  

  • 10. Painful polyneuropathy secondary to prolonged treatment with linezolid: presentation of a case.
    Gil Villar MP; García Arguedas C; Santos Lasaosa S; Cía Blasco P
    Neurologia; 2012 Sep; 27(7):443-5. PubMed ID: 22217521
    [No Abstract]   [Full Text] [Related]  

  • 11. A man in his seventies with a long-term infection and severe acid-base imbalance.
    Holmaas G; Lærum JH; Schjøtt J; Leiva RA
    Tidsskr Nor Laegeforen; 2014 Feb; 134(3):315-9. PubMed ID: 24518482
    [No Abstract]   [Full Text] [Related]  

  • 12. Linezolid use associated with lactic acidosis.
    Kopterides P; Papadomichelakis E; Armaganidis A
    Scand J Infect Dis; 2005; 37(2):153-4. PubMed ID: 15764207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Linezolid-induced lactic acidosis].
    Fernández de Orueta L; Díaz V; Ramírez M; Alvarez R
    Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):550-1. PubMed ID: 19819595
    [No Abstract]   [Full Text] [Related]  

  • 14. Linezolid for the treatment of multidrug-resistant tuberculosis.
    Fortún J; Martín-Dávila P; Navas E; Pérez-Elías MJ; Cobo J; Tato M; De la Pedrosa EG; Gómez-Mampaso E; Moreno S
    J Antimicrob Chemother; 2005 Jul; 56(1):180-5. PubMed ID: 15911549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid-induced lactic acidosis corrected with sustained low-efficiency dialysis: a case report.
    Sawyer AJ; Haley HL; Baty SR; McGuffey GE; Eiland EH
    Am J Kidney Dis; 2014 Sep; 64(3):457-9. PubMed ID: 24961626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactic acidosis and linezolid-induced pancytopaenia.
    Carbajo T; Fenollosa M; Pons R; Calvo C
    Nefrologia; 2011; 31(1):107-8. PubMed ID: 21270922
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prosthetic joint and orthopedic implant infections: side effects of linezolid in prolonged therapy].
    Salinas-Botrán A; Moreno-Parrado L; Vicente-Romero M; Martínez-Alfaro E
    Enferm Infecc Microbiol Clin; 2010; 28(6):394-6. PubMed ID: 20096970
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe lactic acidosis associated with linezolid use in a patient with the mitochondrial DNA A2706G polymorphism.
    Carson J; Cerda J; Chae JH; Hirano M; Maggiore P
    Pharmacotherapy; 2007 May; 27(5):771-4. PubMed ID: 17461714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early development of lactic acidosis with short term linezolid treatment in a renal recipient.
    Lee YR; Powell N; Bonatti H; Sawyer RG; Barroso L; Pruett TL; Sifri CD; Volles D
    J Chemother; 2008 Dec; 20(6):766-7. PubMed ID: 19129081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.